- Home
- TOPS vs PFSA Comparison
TOPS vs PFSA Comparison
Compare TOPS & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- PFSA
- Stock Information
- Founded
- TOPS 2000
- PFSA 2009
- Country
- TOPS Greece
- PFSA United States
- Employees
- TOPS N/A
- PFSA N/A
- Industry
- TOPS Marine Transportation
- PFSA Medical/Dental Instruments
- Sector
- TOPS Consumer Discretionary
- PFSA Health Care
- Exchange
- TOPS Nasdaq
- PFSA Nasdaq
- Market Cap
- TOPS 27.0M
- PFSA 25.1M
- IPO Year
- TOPS 2004
- PFSA N/A
- Fundamental
- Price
- TOPS $6.10
- PFSA $0.24
- Analyst Decision
- TOPS
- PFSA
- Analyst Count
- TOPS 0
- PFSA 0
- Target Price
- TOPS N/A
- PFSA N/A
- AVG Volume (30 Days)
- TOPS 8.4K
- PFSA 13.8M
- Earning Date
- TOPS 11-14-2025
- PFSA 11-20-2025
- Dividend Yield
- TOPS N/A
- PFSA N/A
- EPS Growth
- TOPS N/A
- PFSA N/A
- EPS
- TOPS 2.30
- PFSA N/A
- Revenue
- TOPS $87,872,000.00
- PFSA $75,000.00
- Revenue This Year
- TOPS $9.90
- PFSA N/A
- Revenue Next Year
- TOPS N/A
- PFSA N/A
- P/E Ratio
- TOPS $2.60
- PFSA N/A
- Revenue Growth
- TOPS 4.77
- PFSA 7.14
- 52 Week Low
- TOPS $5.00
- PFSA $0.22
- 52 Week High
- TOPS $11.47
- PFSA $5.50
- Technical
- Relative Strength Index (RSI)
- TOPS 53.96
- PFSA N/A
- Support Level
- TOPS $5.76
- PFSA N/A
- Resistance Level
- TOPS $6.21
- PFSA N/A
- Average True Range (ATR)
- TOPS 0.27
- PFSA 0.00
- MACD
- TOPS 0.01
- PFSA 0.00
- Stochastic Oscillator
- TOPS 64.60
- PFSA 0.00
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.
About PFSA Profusa Inc. Common Stock
Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.